ALT
Altimmune Inc
NASDAQ: ALT · HEALTHCARE · BIOTECHNOLOGY
$2.60
-1.14% today
Updated 2026-04-30
Market cap
$511.15M
P/E ratio
—
P/S ratio
12,467.17x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$3 – $8
Volume
4.1M
Altimmune Inc (ALT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |